Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

WITHDRAWN: A Comparison of Internet Monitoring with Continuous Glucose Monitoring in Insulin-Requiring Type 2 Diabetes Mellitus.

Tildesley HD, Wright AM, Chan JH, Mazanderani AB, Ross SA, Tildesley HG, Lee AM, Tang TS, White AS.

Can J Diabetes. 2016 May;40 Suppl 1:24-7. doi: 10.1016/j.jcjd.2016.04.003. Retraction in: 10.1016/j.jcjd.2016.04.003.

PMID:
27283091
2.

WITHDRAWN: Internet Diabetes Management: A Practical Approach.

Tildesley HD, Chow N, White A, Pawlowska M, Ross SA.

Can J Diabetes. 2016 May;40 Suppl 1:13-7. doi: 10.1016/j.jcjd.2016.04.006. No abstract available. Retraction in: doi: 10.1016/j.jcjd.2016.04.006.

PMID:
27283088
3.

Blood glucose self-monitoring and internet diabetes management on A1C outcomes in patients with type 2 diabetes.

Chow N, Shearer D, Aydin Plaa J, Pottinger B, Pawlowska M, White A, Tildesley HD.

BMJ Open Diabetes Res Care. 2016 Apr 29;4(1):e000134. doi: 10.1136/bmjdrc-2015-000134. eCollection 2016.

4.

Determining starting basal rates of insulin infusion for insulin pump users: a comparison between methods.

Chow N, Shearer D, Tildesley HG, Aydin Plaa J, Pottinger B, Pawlowska M, White A, Priestman A, Ross SA, Tildesley HD.

BMJ Open Diabetes Res Care. 2016 Mar 1;4(1):e000145. doi: 10.1136/bmjdrc-2015-000145. eCollection 2016.

5.

Cost-benefit analysis of internet therapeutic intervention on patients with diabetes.

Deng L, White AS, Pawlowska M, Pottinger B, Aydin J, Chow N, Tildesley HD.

Int J Endocrinol Metab. 2015 Apr 30;13(2):e22803. doi: 10.5812/ijem.22803. eCollection 2015 Apr.

6.

Internet diabetes management: a practical approach.

Tildesley HD, Chow N, White A, Pawlowska M, Ross SA.

Can J Diabetes. 2015 Jun;39(3):195-9. doi: 10.1016/j.jcjd.2014.12.005. Epub 2015 Mar 22. No abstract available.

PMID:
25808591
7.

The effectiveness of Internet intervention on 926 patients with diabetes mellitus for up to 30 months.

Tildesley HD, Conway ME, Deng L, Lee AM, Chan JH, Mazanderani AB, Tildesley HG, White AS, Pawlowska M, Ross SA.

Can J Diabetes. 2015 Jun;39(3):216-20. doi: 10.1016/j.jcjd.2014.10.005. Epub 2015 Jan 23.

PMID:
25623618
8.

Real-time continuous glucose monitoring versus internet-based blood glucose monitoring in adults with type 2 diabetes: a study of treatment satisfaction.

Tang TS, Digby EM, Wright AM, Chan JH, Mazanderani AB, Ross SA, Tildesley HG, Lee AM, White AS, Tildesley HD.

Diabetes Res Clin Pract. 2014 Dec;106(3):481-6. doi: 10.1016/j.diabres.2014.09.050. Epub 2014 Oct 7.

PMID:
25458333
9.

Internet blood glucose monitoring systems provide lasting glycemic benefit in type 1 and 2 diabetes: a systematic review.

Tildesley HD, Po MD, Ross SA.

Med Clin North Am. 2015 Jan;99(1):17-33. doi: 10.1016/j.mcna.2014.08.019. Epub 2014 Oct 18. Review.

PMID:
25456641
10.

The impact on utilities of differences in body weight among Canadian patients with type 2 diabetes.

Lane S, Levy AR, Mukherjee J, Sambrook J, Tildesley H.

Curr Med Res Opin. 2014 Jul;30(7):1267-73. doi: 10.1185/03007995.2014.899207. Epub 2014 Mar 24.

PMID:
24588550
11.

A comparison of internet monitoring with continuous glucose monitoring in insulin-requiring type 2 diabetes mellitus.

Tildesley HD, Wright AM, Chan JH, Mazanderani AB, Ross SA, Tildesley HG, Lee AM, Tang TS, White AS.

Can J Diabetes. 2013 Oct;37(5):305-8. doi: 10.1016/j.jcjd.2013.05.006.

PMID:
24500556
12.

Review of the effect of internet therapeutic intervention in patients with type 1 and type 2 diabetes.

Tildesley HD, Conway ME, Ross SA, Lee AM, Chan JH, Mazanderani AB, Tildesley HG, White AS.

Diabetes Care. 2014 Feb;37(2):e31-2. doi: 10.2337/dc13-1940. Review. No abstract available.

PMID:
24459161
13.

Mind wandering and the adaptive control of attentional resources.

Kam JW, Dao E, Stanciulescu M, Tildesley H, Handy TC.

J Cogn Neurosci. 2013 Jun;25(6):952-60. doi: 10.1162/jocn_a_00375. Epub 2013 Feb 28.

PMID:
23448525
14.

Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes.

Ross SA, Tildesley HD, Ashkenas J.

Curr Med Res Opin. 2011 Nov;27 Suppl 3:13-20. doi: 10.1185/03007995.2011.621416. Epub 2011 Sep 23.

PMID:
21942467
15.

Effect of Internet therapeutic intervention on A1C levels in patients with type 2 diabetes treated with insulin.

Tildesley HD, Mazanderani AB, Ross SA.

Diabetes Care. 2010 Aug;33(8):1738-40. doi: 10.2337/dc09-2256.

16.

Patient preferences for diabetic retinopathy health States.

Szabo SM, Beusterien KM, Pleil AM, Wirostko B, Potter MJ, Tildesley H, Gonder J, Barsdorf A, Levy AR.

Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3387-94. doi: 10.1167/iovs.09-4194. Epub 2010 Jan 6.

PMID:
20053977
17.

Apolipoprotein B levels in adults with type 1 diabetes not receiving lipid-lowering therapy.

Mazanderani AB, Wise SJ, Tildesley HD.

Clin Biochem. 2009 Aug;42(12):1218-21. doi: 10.1016/j.clinbiochem.2009.05.013. Epub 2009 Jun 1. Erratum in: Clin Biochem. 2010 Jun;43(9):791.

PMID:
19497316
18.

Low Prevalence of Elevated ApoB Levels in Patients with Type 2 Diabetes Not Receiving Lipid-Lowering Therapy.

Tildesley H, Fraser T, Wise S, Mazanderani A, Aydin C, Johns K, Yu E, Bondy G.

Can J Diabetes. 2009;33(3):163-9. doi: 10.1016/S1499-2671(09)33007-5. Epub 2012 Dec 10.

PMID:
25998591
19.

Sex disparities in effects of cystic fibrosis-related diabetes on clinical outcomes: a matched study.

Miller RJ, Tildesley HD, Wilcox PG, Zhang H, Kreisman SH.

Can Respir J. 2008 Sep;15(6):291-4.

20.

The Kelowna Diabetes Program: Bridging the Gap Between Testing Guidelines and Reality.

Innes D, Cameron D, Farquhar A, Tildesley H, Green L, Fraser T.

Can J Diabetes. 2008;32(2):107-13. doi: 10.1016/S1499-2671(08)22007-1. Epub 2012 Dec 10.

PMID:
27056539
21.

Sweet success.

Innes D, Farquhar A, Cameron D, Tildesley H.

Can Fam Physician. 2007 Apr;53(4):624-5. No abstract available.

22.

Sulfonylurea therapy is associated with increased NT-proBNP levels in the treatment of type 2 diabetes.

Tildesley HD, Aydin CM, Ignaszewski A, Strelzow JA, Yu E, Bondy G.

Int J Cardiol. 2007 Feb 14;115(3):312-7. Epub 2006 Jul 7.

PMID:
16824633
23.

Gestational diabetes mellitus outcome in 394 patients.

Johns K, Olynik C, Mase R, Kreisman S, Tildesley H.

J Obstet Gynaecol Can. 2006 Feb;28(2):122-7.

PMID:
16643713
24.

Metformin's contraindications should be contraindicated.

McCormack J, Johns K, Tildesley H.

CMAJ. 2005 Aug 30;173(5):502-4. Review. No abstract available.

25.

Differences in diabetic co-morbidity between Aboriginal and non-Aboriginal people living in Bella Coola, Canada.

Thommasen HV, Patenaude J, Anderson N, Mc Arthur A, Tildesley H.

Rural Remote Health. 2004 Oct-Dec;4(4):319. Epub 2004 Oct 8.

26.

Effective exercise modality to reduce insulin resistance in women with type 2 diabetes.

Cuff DJ, Meneilly GS, Martin A, Ignaszewski A, Tildesley HD, Frohlich JJ.

Diabetes Care. 2003 Nov;26(11):2977-82.

PMID:
14578226
27.

Effects of 3 months of continuous subcutaneous administration of glucagon-like peptide 1 in elderly patients with type 2 diabetes.

Meneilly GS, Greig N, Tildesley H, Habener JF, Egan JM, Elahi D.

Diabetes Care. 2003 Oct;26(10):2835-41.

PMID:
14514588
28.

Diabetes Screening in Canada (DIASCAN) Study: prevalence of undiagnosed diabetes and glucose intolerance in family physician offices.

Leiter LA, Barr A, BĂ©langer A, Lubin S, Ross SA, Tildesley HD, Fontaine N; Diabetes Screening in Canada (DIASCAN) Study.

Diabetes Care. 2001 Jun;24(6):1038-43.

PMID:
11375367
29.

Significance of GAD positivity in elderly patients with diabetes.

Meneilly GS, Tildesley H, Elliott T, Palmer JP, Juneja R.

Diabet Med. 2000 Mar;17(3):247-8. No abstract available.

PMID:
10784232
30.

Post-transplant diabetic ketoacidosis--a possible consequence of immunosuppression with calcineurin inhibiting agents: a case series.

Yoshida EM, Buczkowski AK, Sirrs SM, Elliott TG, Scudamore CH, Levin A, Tildesley HD, Landsberg DN.

Transpl Int. 2000;13(1):69-72.

PMID:
10743693
31.

Alterations in non-insulin-mediated glucose uptake in the elderly patient with diabetes.

Forbes A, Elliott T, Tildesley H, Finegood D, Meneilly GS.

Diabetes. 1998 Dec;47(12):1915-9.

PMID:
9836524
32.

Effect of continuous subcutaneous insulin infusion with lispro on hepatic responsiveness to glucagon in type 1 diabetes.

Launay B, Zinman B, Tildesley HD, Strack T, Chiasson JL.

Diabetes Care. 1998 Oct;21(10):1627-31.

PMID:
9773721
33.

Counterregulatory hormone responses after long-term continuous subcutaneous insulin infusion with lispro insulin.

Tsui EY, Chiasson JL, Tildesley H, Barnie A, Simkins S, Strack T, Zinman B.

Diabetes Care. 1998 Jan;21(1):93-6.

PMID:
9538976
34.

Insulin lispro in CSII: results of a double-blind crossover study.

Zinman B, Tildesley H, Chiasson JL, Tsui E, Strack T.

Diabetes. 1997 Mar;46(3):440-3. Erratum in: Diabetes 1997 Jul;46(7):1239.

PMID:
9032100
35.

NIDDM in the elderly.

Meneilly GS, Elliott T, Tessier D, Hards L, Tildesley H.

Diabetes Care. 1996 Dec;19(12):1320-5.

PMID:
8941457
36.

Diabetes teaching--outcome analysis.

Tildesley HD, Mair K, Sharpe J, Piaseczny M.

Patient Educ Couns. 1996 Oct;29(1):59-65.

PMID:
9006222
37.

Syndrome of inappropriate secretion of antidiuretic hormone in association with chlorpromazine ingestion.

Tildesley HD, Toth E, Crockford PM.

Can J Psychiatry. 1983 Oct;28(6):487-8.

PMID:
6640486

Supplemental Content

Loading ...
Support Center